Active Ingredient History
Pneumococcal conjugate vaccine is a pneumococcal vaccine made with the conjugate vaccine method and used to protect infants, young children, and adults against disease caused by the bacterium Streptococcus pneumoniae (pneumococcus). It contains purified capsular polysaccharide of pneumococcal serotypes conjugated to a carrier protein to improve antibody response compared to the pneumococcal polysaccharide vaccine. The World Health Organization (WHO) recommends the use of the conjugate vaccine in routine immunizations given to children. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bacterial Infections (Phase 3)
Cough (Phase 4)
Diphtheria (Phase 3)
Fever (Phase 4)
Haemophilus influenzae type b (Phase 3)
Hepatitis B (Phase 2)
Immunization (Phase 4)
Malaria (Phase 3)
Malaria Vaccines (Phase 3)
Meningitis (Phase 3)
Meningococcal Infections (Phase 3)
Otitis Media (Phase 4)
Pertussis Vaccine (Phase 3)
Pneumococcal Infections (Phase 4)
Pneumonia (Phase 4)
Pneumonia, Pneumococcal (Phase 4)
Pneumonia, Staphylococcal (Phase 3)
Poliomyelitis (Phase 3)
Respiratory Syncytial Virus Infections (Phase 1)
Respiratory Tract Infections (Phase 4)
Rotavirus Infections (Phase 3)
Sepsis (Phase 3)
Streptococcal Infections (Phase 3)
Tetanus (Phase 3)
Vaccination (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue